$50.42 +1.20 (%) Bristol Myers Squibb Co - NYSE

Oct. 17, 2014 | 04:00 PM

Partner Headlines

  1. Weekly CFO Sells Highlight: Williams Companies Inc, Google Inc, Bristol-Myers Squibb Company

    GuruFocus | Oct. 19, 2014 | 14:09PM EST
  2. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga | Oct. 19, 2014 | 10:19AM EST
  3. Apple Leads the Charge as Earnings Season Heats Up

    FoxBusiness | Oct. 17, 2014 | 16:48PM EST
  4. The Six Types of Winning Stocks

    GuruFocus | Oct. 17, 2014 | 14:38PM EST
  5. Markets Debut Week On Negative Note; S&P 500 Falls Through Key Level

    Benzinga | Oct. 13, 2014 | 16:57PM EST
  6. Merck to release hep C data

    IBD | Oct. 8, 2014 | 18:38PM EST
  7. Merck, Bristol, Arrowhead Prep Hepatitis Studies

    IBD | Oct. 8, 2014 | 13:36PM EST
  8. Salix, Actavis Among Big Cap Pharmas In Merger Mambo

    IBD | Oct. 7, 2014 | 19:33PM EST
  9. Bristol-Myers pulls FDA filing

    IBD | Oct. 7, 2014 | 18:49PM EST
  10. Bristol-Myers Pulls FDA Filing For 2-Drug Hep C Combo

    IBD | Oct. 7, 2014 | 11:13AM EST
  11. Bristol-Myers Squibb Statement About Asunaprevir In The US, WIthdraws NDA

    Benzinga | Oct. 7, 2014 | 08:32AM EST
  12. 2 Mutual Funds Holding Hospital Stocks

    Benzinga | Oct. 6, 2014 | 10:38AM EST
  13. NeurOp Receives Milestone Payment As Bristol-Myers Squibb Nominates NMDA Receptor Compound As Candidate For Drug Development

    Benzinga | Oct. 2, 2014 | 15:16PM EST
  14. Morgan Stanley Believes Bristol-Myers Squibb Co. Could Move Significantly Over Next Several Months

    Benzinga | Oct. 2, 2014 | 10:15AM EST
  15. Gilead's New HIV Drug Key To Long-Term Strategy

    IBD | Sep. 24, 2014 | 17:29PM EST
  16. Gilead OKs Generic Sovaldi To Expand Global Access

    IBD | Sep. 15, 2014 | 11:35AM EST
  17. Bristol-Myers Squibb Co In Patent Suit Vs. Merck & Co., Inc. Over Skin Cancer Drug

    Benzinga | Sep. 5, 2014 | 16:04PM EST
  18. Merck PD-1 Inhibitor Approved For Skin Cancer

    IBD | Sep. 4, 2014 | 16:33PM EST
  19. Drug M&A Boom Driven By Long-Term Trends: PwC

    IBD | Sep. 3, 2014 | 16:22PM EST
  20. Booming Biotech Market Benefits REIT BioMed Realty

    IBD | Sep. 2, 2014 | 17:42PM EST
  21. Bristol-Myers: Absolute Valuation Model versus Relative Valuation Model

    GuruFocus | Aug. 29, 2014 | 11:04AM EST
  22. Bristol-Myers Drug Gets OK

    IBD | Aug. 27, 2014 | 18:56PM EST
  23. Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend

    Benzinga | Aug. 27, 2014 | 17:17PM EST
  24. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

    Benzinga | Aug. 27, 2014 | 12:32PM EST
  25. Bristol-Myers Hepatitis C Therapy Approved in EU

    IBD | Aug. 27, 2014 | 12:03PM EST
  26. US Stock Futures Edge Higher Ahead Of Tiffany Earnings

    Benzinga | Aug. 27, 2014 | 07:07AM EST
  27. Merck, Pfizer Combining Drugs In Lung Cancer Study

    IBD | Aug. 26, 2014 | 12:07PM EST
  28. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD | Aug. 12, 2014 | 10:48AM EST
  29. Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments

    Benzinga | Aug. 11, 2014 | 16:46PM EST
  30. Drugmaker AstraZeneca Returns To Growth

    IBD | Aug. 5, 2014 | 17:22PM EST
  31. The Stocks Already in Correction Mode

    FoxBusiness | Aug. 1, 2014 | 08:15AM EST
  32. Will ImmunoGen's Q4 Earnings Disappoint Again?

    GuruFocus | Jul. 30, 2014 | 19:21PM EST
  33. Bristol-Myers surprises Street

    IBD | Jul. 24, 2014 | 18:57PM EST
  34. Thursday Morning Earnings Reports

    Benzinga | Jul. 24, 2014 | 12:14PM EST
  35. Stock Futures Steer Higher; Facebook, Skechers Nail Q2 Wins

    IBD | Jul. 24, 2014 | 09:09AM EST
  36. Earnings Scheduled For July 24, 2014

    Benzinga | Jul. 24, 2014 | 05:31AM EST
  37. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD | Jul. 19, 2014 | 08:02AM EST
  38. Benzinga Weekly Preview: Earnings Season Continues With Geopolitical Tensions As A Backdrop

    Benzinga | Jul. 18, 2014 | 16:47PM EST
  39. UnitedHealth Group Up on Weak Day for the Dow

    GuruFocus | Jul. 17, 2014 | 18:57PM EST
  40. Dow Sets New Intraday High; Citigroup Impresses With Earnings

    Benzinga | Jul. 14, 2014 | 16:44PM EST
  41. Senators Ask Gilead To Explain Sovaldi Pricing

    IBD | Jul. 11, 2014 | 11:35AM EST
  42. Bristol seeks cancer drug nod

    IBD | Jul. 10, 2014 | 18:45PM EST
  43. Bristol-Myers Seeking Nivolumab Approval In Melanoma

    IBD | Jul. 10, 2014 | 10:24AM EST
  44. Japan approves BMY regimen

    IBD | Jul. 7, 2014 | 18:58PM EST
  45. Jazz, Novo Among Medicals Showing Healthy Action

    IBD | Jul. 7, 2014 | 18:18PM EST
  46. Bristol-Myers' All-Oral HCV Therapy Approved In Japan

    IBD | Jul. 7, 2014 | 12:23PM EST
  47. Merck, Gilead Lead Race To Eradicate Hepatitis C

    IBD | Jul. 3, 2014 | 17:08PM EST
  48. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga | Jul. 2, 2014 | 16:34PM EST
  49. Barclays Downgrades Pharmaceutical Sector

    Benzinga | Jul. 2, 2014 | 15:31PM EST
  50. UPDATE: Barclays Downgrades Bristol-Myers, Cuts Price Target By 41%

    Benzinga | Jul. 2, 2014 | 10:06AM EST
Trading Center